Mambetsariev Isa相关文献与解析，生知库 | 链接生命科学的每一步

Miyamura, Beatriz Viesser; Mambetsariev, Isa; Fricke, Jeremy; Arias-Romero, Javier; Cadman, Karla; Shrestha, Sagun; Pisick, Evan; Nguyen, Danny; Malhotra, Jyoti; Reyes, Amanda; Salgia, Ravi

肺癌

肿瘤

肿瘤免疫

Diversity of BRAF mutations in non-small cell lung cancer and implications on treatment

非小细胞肺癌中BRAF突变的多样性及其对治疗的影响

期刊:npj Precision Oncology

影响因子:8

doi:10.1038/s41698-025-01089-z

Lu, Kevin; Shen, John Paul; Lopez-Diaz, Fernando J; Leal, Alessandro; Mambetsariev, Isa; Parikh, Kaushal; Hazim, Antonious; Woodward, Brian D; Madduri, Abhinav; Khurshid, Faisal; Fricke, Jeremy; Velcheti, Vamsidhar; Riess, Jonathan W; Mansfield, Aaron S; Salgia, Ravi; Husain, Hatim

Current Clinical Paradigm and Therapeutic Advancements in Thymic Malignancies: A Narrative Review

胸腺恶性肿瘤的当前临床范式和治疗进展：叙述性综述

期刊:Cancers

影响因子:4.4

doi:10.3390/cancers17223622

Dias E Silva, Douglas; Miyamura, Beatriz Viesser; Mambetsariev, Isa; Fricke, Jeremy; Arias-Romero, Javier; Kulkarni, Amit A; Khan, Ajaz; Bruno, Debora S; Malhotra, Jyoti; Fong, Abigail; Kim, Jae; Ladbury, Colton; Amini, Arya; Schvartsman, Gustavo; Salgia, Ravi

Novel LZTR1 germline mutation as a mechanism of resistance to osimertinib in EGFR-mutated lung adenocarcinoma: a case report

新型LZTR1种系突变作为EGFR突变型肺腺癌对奥希替尼耐药的机制：病例报告

期刊:Translational Lung Cancer Research

影响因子:3.5

doi:10.21037/tlcr-24-723

Park, Wai; Fricke, Jeremy; Mambetsariev, Isa; Velasquez, Giovanny; Nadaf-Rahrov, Reza; Dingal, Shaira Therese; Kim, Pauline; Babikian, Razmig; Amini, Arya; Afkhami, Michelle; Salgia, Ravi

Small Cell Transformation of EGFR-Mutant NSCLC Treated with Tyrosine Kinase Inhibition

酪氨酸激酶抑制剂治疗EGFR突变型非小细胞肺癌的小细胞转化

期刊:Current Oncology

影响因子:3.4

doi:10.3390/curroncol32100554

Rock, Adam; Mambetsariev, Isa; Pareek, Siddhika; Fricke, Jeremy; Li, Xiaochen; Arias-Romero, Javier; Kareem, Waasil; Arvanitis, Leonidas; Bruno, Debora S; Gray, Stacy; Salgia, Ravi

Cancer Survival at a Comprehensive Cancer Center Compared with Surveillance, Epidemiology, and End Results (SEER) Estimates

综合癌症中心癌症生存率与监测、流行病学和最终结果 (SEER) 估计值的比较

期刊:

影响因子:

doi:10.1101/2025.09.05.25335204

Salgia, Ravi; Alvarnas, Joseph; Trisal, Vijay; Vanderplas, Ann; Li, Xiaochen; Arias-Romero, Javier; Fricke, Jeremy; Frankel, Paul; Mambetsariev, Isa; Rice, Hannah; Levine, Harlan; van den Brink, Marcel R M

Spatial iTME analysis of KRAS mutant NSCLC and immunotherapy outcome

KRAS突变型非小细胞肺癌的空间iTME分析及免疫治疗结果

期刊:npj Precision Oncology

影响因子:8

doi:10.1038/s41698-024-00626-6

Zhao, Dan; Li, Haiqing; Mambetsariev, Isa; Mirzapoiazova, Tamara; Chen, Chen; Fricke, Jeremy; Wheeler, Deric; Arvanitis, Leonidas; Pillai, Raju; Afkhami, Michelle; Chen, Bihong T; Sattler, Martin; Erhunmwunsee, Loretta; Massarelli, Erminia; Kulkarni, Prakash; Amini, Arya; Armstrong, Brian; Salgia, Ravi

Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series

免疫检查点抑制剂肾炎的临床特征：单中心临床病例系列研究

期刊:Cancer Immunology Immunotherapy

影响因子:5.1

doi:10.1007/s00262-024-03775-6

Muddasani, Ramya; Talwar, Neel; Mambetsariev, Isa; Fricke, Jeremy; Lin, Mercury; Schmolze, Daniel; Yue, Andrew; Rizvi, Amna; Salgia, Ravi

A novel HLA-DQB2::MET gene fusion variant in lung adenocarcinoma with prolonged response to tepotinib: a case report

一例对替泊替尼治疗反应持久的肺腺癌中新型HLA-DQB2::MET基因融合变异病例报告

期刊:Translational Lung Cancer Research

影响因子:3.5

doi:10.21037/tlcr-24-34

Dias E Silva, Douglas; Mambetsariev, Isa; Fricke, Jeremy; Babikian, Razmig; Dingal, Shaira Therese; Mazdisnian, Farhad; Badie, Behnam; Arvanitis, Leonidas; Afkhami, Michelle; Villalona-Calero, Miguel; Salgia, Ravi

RBM10 Mutation as a Potential Negative Prognostic/Predictive Biomarker to Therapy in Non-Small-Cell Lung Cancer

RBM10突变作为非小细胞肺癌治疗中潜在的负性预后/预测生物标志物

期刊:Clinical Lung Cancer

影响因子:3.3

doi:10.1016/j.cllc.2024.07.010

Reyes, Amanda; Afkhami, Michelle; Massarelli, Erminia; Fricke, Jeremy; Mambetsariev, Isa; Li, Xiaochen; Velasquez, Giovanny; Salgia, Ravi

Current paradigm of EGFR(ins20) in non-small cell lung cancer: A long way forward

非小细胞肺癌中 EGFR(ins20) 的当前范式：前路漫漫

Diversity of BRAF mutations in non-small cell lung cancer and implications on treatment

非小细胞肺癌中BRAF突变的多样性及其对治疗的影响

Current Clinical Paradigm and Therapeutic Advancements in Thymic Malignancies: A Narrative Review

胸腺恶性肿瘤的当前临床范式和治疗进展：叙述性综述

Novel LZTR1 germline mutation as a mechanism of resistance to osimertinib in EGFR-mutated lung adenocarcinoma: a case report

新型LZTR1种系突变作为EGFR突变型肺腺癌对奥希替尼耐药的机制：病例报告

Small Cell Transformation of EGFR-Mutant NSCLC Treated with Tyrosine Kinase Inhibition

酪氨酸激酶抑制剂治疗EGFR突变型非小细胞肺癌的小细胞转化

Cancer Survival at a Comprehensive Cancer Center Compared with Surveillance, Epidemiology, and End Results (SEER) Estimates

综合癌症中心癌症生存率与监测、流行病学和最终结果 (SEER) 估计值的比较

Spatial iTME analysis of KRAS mutant NSCLC and immunotherapy outcome

KRAS突变型非小细胞肺癌的空间iTME分析及免疫治疗结果

Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series

免疫检查点抑制剂肾炎的临床特征：单中心临床病例系列研究

A novel HLA-DQB2::MET gene fusion variant in lung adenocarcinoma with prolonged response to tepotinib: a case report

一例对替泊替尼治疗反应持久的肺腺癌中新型HLA-DQB2::MET基因融合变异病例报告

RBM10 Mutation as a Potential Negative Prognostic/Predictive Biomarker to Therapy in Non-Small-Cell Lung Cancer

RBM10突变作为非小细胞肺癌治疗中潜在的负性预后/预测生物标志物